Ardea Biosciences, Inc. (RDEA) Reports Q1 Loss of $1.25/Share

Ardea Biosciences, Inc. (NASDAQ: RDEA) reported Q1 EPS of ($1.25), $0.27 worse than the analyst estimate of ($0.98). Revenue for the quarter came in at $1.5 million versus the consensus estimate of $3 million.

For earnings history and earnings-related data on Ardea Biosciences, Inc. (RDEA) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• United Airlines maintains forecast after Q1 results top Wall Street estimates
• United States Steel Corporation to Release First Quarter 2024 Financial Results on May 2, 2024
• OPENLANE to Announce First Quarter 2024 Earnings